HDL markers in cardiovascular risk prediction: Ethnicity matters
- 2 September 2020
- journal article
- editorial
- Published by Elsevier BV in Atherosclerosis
- Vol. 311, 105-106
- https://doi.org/10.1016/j.atherosclerosis.2020.08.020
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and EthnicityJournal of the American College of Cardiology, 2020
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskEuropean Heart Journal, 2019
- Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular EventsJournal of the American College of Cardiology, 2017
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular DiseaseThe New England Journal of Medicine, 2017
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeThe New England Journal of Medicine, 2012
- High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events: MESA (Multi-Ethnic Study of Atherosclerosis)Journal of Invasive Cardiology, 2012
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin TherapyThe New England Journal of Medicine, 2011
- LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL managementJournal of Clinical Lipidology, 2007
- Effects of Torcetrapib in Patients at High Risk for Coronary EventsThe New England Journal of Medicine, 2007
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEuropean Heart Journal, 2003